Valve Heart Disease Clinical Trial
Official title:
Prospective Evaluation of Volatile Sedation With Regard to Awakening Behaviour and Extubation Capacity in Patients Undergoing Heart Valve Surgery
Verified date | January 2024 |
Source | Goethe University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cardiac surgery is a complex operative procedure with a substantial risk of postoperative complications, so that patients undergoing valve surgery are usually transferred to the intensive care unit postoperatively. Various substances are used to maintain the required sedation, such as volatile anaesthetics and intravenous sedatives combined with analgetic therapy using opioids. The study intends to investigate to what extent the already well-described effect of volatile anaesthetics on recovery can be realised despite the need for differentiated intensive care and medical management.
Status | Completed |
Enrollment | 100 |
Est. completion date | December 1, 2023 |
Est. primary completion date | August 28, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Valve reconstruction or valve replacement - Must be capable to giving written consent Exclusion Criteria: - Intolerance to volatile anaesthetics (e.g. malignant hyperthermia) - Severe obstructive pulmonary disease - Extended aortic arch or ascending aorta surgery - Age <18 years |
Country | Name | City | State |
---|---|---|---|
Germany | University Hospital Frankfurt | Frankfurt | Hessen |
Lead Sponsor | Collaborator |
---|---|
Goethe University |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to extubation | Time from admission on ICU until awakening and Extubation. | through study completion, an average of 2 days | |
Secondary | Time to neurocognitive assessability | Time from admission on ICU until awake and neurocognitive assessable. | through study completion, an average of 2 days | |
Secondary | Required setup time of the intensive care workplace | Required setup time of the intensive care workplace to provide volatile or intravenous sedation. | through study completion, up to 24 hours | |
Secondary | Factor related to the course of intensive care: blood loss | Measured Postoperative Blood Loss | through study completion, an average of 24 hours | |
Secondary | Factor related to the course of intensive care: kidney injury | Measured increases in serum renal retention levels: creatinine and urea in terms of renal failure according to Kidney Disease - Improving Global Outcomes (KDIGO) criteria. | through study completion, an average of 24 hours | |
Secondary | Factor related to the course of intensive care: acid-base balance | Measured serum lactate levels and hypercapnia | through study completion, an average of 24 hours | |
Secondary | Factor related to the course of intensive care: lung function parameters | Required inspiratory oxygen fraction | through study completion, an average of 24 hours | |
Secondary | Factor related to the course of intensive care:cardiovascular medication | Required dosage of adrenaline, noradrenaline, vasopressin or milrinone | through study completion, an average of 24 hours | |
Secondary | Factors related to the course of operative procedure | time of the intraoperative procedure including the heart-lung-machine | through study completion, up to 24 hours | |
Secondary | Intra-hospital mortality | Intra-hospital mortality - Safety outcome | through study completion, an average of 7 days | |
Secondary | Liver failure | Intra-hospital liver failure - Safety outcome | through study completion, an average of 7 days | |
Secondary | postoperative nausea and vomiting | Detection of postoperative nausea and vomiting | through study completion, up to 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06066970 -
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
|
||
Recruiting |
NCT05079672 -
Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery
|
Phase 4 | |
Completed |
NCT03347851 -
Post-surgical Aortic Hemodynamics After Aortic Valve Replacement
|
||
Active, not recruiting |
NCT03539458 -
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
|
N/A | |
Completed |
NCT04328090 -
Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship
|
N/A | |
Recruiting |
NCT04359030 -
Freestyle-Perimount Calcification Comparison
|
||
Completed |
NCT04598360 -
Release of Epoxyeicosatrienoic Acids From Erythrocytes During the Use of Extracorporeal Procedures (Heart-lung Machine)
|
N/A | |
Not yet recruiting |
NCT04118621 -
Role of Chest Ultrasound in Detection of Post-operative Pulmonary Complications After Cardiothoracic Surgery
|
||
Recruiting |
NCT06387446 -
Allogeneic Valve Transplantation
|
N/A | |
Recruiting |
NCT04843072 -
Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
|
N/A | |
Completed |
NCT05804500 -
RecoveryPlus Telerehab Platform Pilot Study
|
N/A | |
Recruiting |
NCT03885180 -
Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy
|
N/A | |
Completed |
NCT06154018 -
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
|
N/A | |
Recruiting |
NCT06041308 -
Bioprothetic Valve Versus Mechanical Valve of Bioprothetic Valve Versus Mechanical Valve
|
||
Suspended |
NCT01571791 -
Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery
|
Phase 2 | |
Completed |
NCT06261788 -
Efficacy and Safety of the Sync-AV II Temporary Cardiac Pacing Catheter
|
N/A | |
Completed |
NCT06079008 -
The Association of Cardiac Valve Calcification and 1-year Mortality After Lower-extremity Amputation in Diabetic Patients
|
||
Completed |
NCT04372654 -
Pilot Study Evaluating the Safety of Electroducer Sleeve Medical Device for Temporary Cardiac Stimulation During Percutaneous Cardiovascular Interventions, in All Kind of Patients
|
N/A | |
Active, not recruiting |
NCT03661398 -
Caisson Transcatheter Mitral Valve Replacement (TMVR)
|
N/A | |
Recruiting |
NCT03595423 -
SPAnish Aortic VALVE Multicentric Study
|